Genflow Biosciences plc (LON:GENF – Get Free Report) was up 1.5% on Monday. The company traded as high as GBX 1.88 and last traded at GBX 1.88. Approximately 2,498,556 shares changed hands during trading, an increase of 10% from the average session volume of 2,269,347 shares. The stock had previously closed at GBX 1.85.
Genflow Biosciences Trading Up 4.1%
The company has a fifty day simple moving average of GBX 1.97 and a 200-day simple moving average of GBX 2.03. The company has a market capitalization of £11.30 million, a PE ratio of -8.64 and a beta of 2.29.
Genflow Biosciences (LON:GENF – Get Free Report) last issued its earnings results on Tuesday, September 29th. The company reported GBX (0.08) earnings per share (EPS) for the quarter. Genflow Biosciences had a positive return on equity of 609.63% and a negative net margin of 187.87%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Recommended Stories
- Five stocks we like better than Genflow Biosciences
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
